130 related articles for article (PubMed ID: 28782758)
21. C5a receptors on neutrophils and monocytes from chronic dialysis patients.
Lewis SL
Adv Exp Med Biol; 1991; 297():167-81. PubMed ID: 1767749
[No Abstract] [Full Text] [Related]
22. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
[TBL] [Abstract][Full Text] [Related]
23. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.
Flierl MA; Schreiber H; Huber-Lang MS
J Invest Surg; 2006; 19(4):255-65. PubMed ID: 16835140
[TBL] [Abstract][Full Text] [Related]
24. A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a.
Hünniger K; Bieber K; Martin R; Lehnert T; Figge MT; Löffler J; Guo RF; Riedemann NC; Kurzai O
J Immunol; 2015 Feb; 194(3):1199-210. PubMed ID: 25539819
[TBL] [Abstract][Full Text] [Related]
25. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T
Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844
[TBL] [Abstract][Full Text] [Related]
26. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
Lee H; Whitfeld PL; Mackay CR
Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
[TBL] [Abstract][Full Text] [Related]
27. Complement inhibition keeps mothers calm and avoids fetal rejection.
Girardi G
Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
[TBL] [Abstract][Full Text] [Related]
28. C5a receptor antagonists for the treatment of inflammation.
Sumichika H
Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
[TBL] [Abstract][Full Text] [Related]
29. Bacterial chaperone protein, Skp, induces leukocyte chemotaxis via C5a receptor.
Shrestha A; Shi L; Tanase S; Tsukamoto M; Nishino N; Tokita K; Yamamoto T
Am J Pathol; 2004 Mar; 164(3):763-72. PubMed ID: 14982830
[TBL] [Abstract][Full Text] [Related]
30. C5a and pain development: An old molecule, a new target.
Quadros AU; Cunha TM
Pharmacol Res; 2016 Oct; 112():58-67. PubMed ID: 26855316
[TBL] [Abstract][Full Text] [Related]
31. Distinct neutrophil C5a receptor inflammatory events in cows initiated by chemoattractant C5a and lipopolysaccharide around parturition and in mid lactation.
Boulougouris X; Rogiers C; Van Poucke M; De Spiegeleer B; Peelman LJ; Duchateau L; Burvenich C
J Dairy Sci; 2019 Feb; 102(2):1457-1472. PubMed ID: 30594380
[TBL] [Abstract][Full Text] [Related]
32. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
33. Expressions of C5a and its receptor CD88 after spinal cord injury in C3-deficient mice.
Guo Q; Cheng J; Zhang H; Zhang J; Su B; Bian C; Lin S
Scand J Immunol; 2013 Apr; 77(4):224-9. PubMed ID: 23033813
[TBL] [Abstract][Full Text] [Related]
34. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.
Mahajan SD; Parikh NU; Woodruff TM; Jarvis JN; Lopez M; Hennon T; Cunningham P; Quigg RJ; Schwartz SA; Alexander JJ
Immunology; 2015 Sep; 146(1):130-43. PubMed ID: 26059553
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor.
van den Berg CW; Tambourgi DV; Clark HW; Hoong SJ; Spiller OB; McGreal EP
J Immunol; 2014 Feb; 192(4):1787-95. PubMed ID: 24446515
[TBL] [Abstract][Full Text] [Related]
36. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
37. Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.
Kourtzelis I; Markiewski MM; Doumas M; Rafail S; Kambas K; Mitroulis I; Panagoutsos S; Passadakis P; Vargemezis V; Magotti P; Qu H; Mollnes TE; Ritis K; Lambris JD
Blood; 2010 Jul; 116(4):631-9. PubMed ID: 20424189
[TBL] [Abstract][Full Text] [Related]
38. Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2.
Hawksworth OA; Coulthard LG; Taylor SM; Wolvetang EJ; Woodruff TM
Stem Cells; 2014 Dec; 32(12):3278-84. PubMed ID: 25132103
[TBL] [Abstract][Full Text] [Related]
39. Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.
Kumar PKR
Mol Biol Rep; 2018 Oct; 45(5):851-864. PubMed ID: 29981048
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of C5a receptors on neutrophils from cord blood.
Nybo M; Sørensen O; Leslie R; Wang P
Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F129-32. PubMed ID: 9577284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
